论文部分内容阅读
Tumor initiating cells play important roles in multiple myeloma (MM) progression,relapse,recurrence,and are critical target for therapy.However,quite few agents have been shown to target tumor initiating cells,representing challenges in the treatment of MM.The biomarker for myeloma stem cells is still unclear.